These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 38862474)
1. The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation. Lin M; Zheng X; Yan J; Huang F; Chen Y; Ding R; Wan J; Zhang L; Wang C; Pan J; Cao X; Fu K; Lou Y; Feng XH; Ji J; Zhao B; Lan F; Shen L; He X; Qiu Y; Jin J Nat Commun; 2024 Jun; 15(1):4995. PubMed ID: 38862474 [TBL] [Abstract][Full Text] [Related]
2. Phase separation of RNF214 promotes the progression of hepatocellular carcinoma. He ZJ; He K; Cai SW; Zhang R; Shao ZB; Wang ST; Li XP; Li YC; Liu WJ; Zhu YQ; Zeng SJ; Su YB; Shi Z Cell Death Dis; 2024 Jul; 15(7):483. PubMed ID: 38969650 [TBL] [Abstract][Full Text] [Related]
3. Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis. Shu Y; Jin X; Ji M; Zhang Z; Wang X; Liang H; Lu S; Dong S; Lin Y; Guo Y; Zhuang Q; Wang Y; Lei Z; Guo L; Meng X; Zhou G; Zhang W; Chang L Cancer Res; 2024 Sep; 84(17):2836-2855. PubMed ID: 38862269 [TBL] [Abstract][Full Text] [Related]
4. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation. Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853 [TBL] [Abstract][Full Text] [Related]
5. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice. Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333 [TBL] [Abstract][Full Text] [Related]
6. YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma. Li Z; Su P; Yu M; Zhang X; Xu Y; Jia T; Yang P; Zhang C; Sun Y; Li X; Yang H; Ding Y; Zhuang T; Guo H; Zhu J Sci Signal; 2024 Jul; 17(843):eadk0231. PubMed ID: 38954637 [TBL] [Abstract][Full Text] [Related]
7. CRKL Enhances YAP Signaling through Binding and JNK/JUN Pathway Activation in Liver Cancer. Wesener MC; Weiler SME; Bissinger M; Klessinger TF; Rose F; Merker S; Luzarowski M; Ruppert T; Helm B; Klingmüller U; Schirmacher P; Breuhahn K Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126118 [TBL] [Abstract][Full Text] [Related]
8. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway. Shu B; Zhou Y; Lei G; Peng Y; Ding C; Li Z; He C Cancer Sci; 2024 May; 115(5):1476-1491. PubMed ID: 38475938 [TBL] [Abstract][Full Text] [Related]
9. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2. Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938 [No Abstract] [Full Text] [Related]
10. Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors. Akrida I; Makrygianni M; Nikou S; Mulita F; Bravou V; Papadaki H Pathol Res Pract; 2024 Oct; 262():155551. PubMed ID: 39153238 [TBL] [Abstract][Full Text] [Related]
11. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway. Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566 [TBL] [Abstract][Full Text] [Related]
12. YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells. Li S; Li X; Yang YB; Wu SF Apoptosis; 2024 Aug; 29(7-8):1198-1210. PubMed ID: 38553612 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma. Zhang C; Wei W; Tu S; Liang B; Li C; Li Y; Luo W; Wu Y; Dai X; Wang Y; Zheng L; Hao L; Zhang C; Luo Z; Chen YG; Yan X J Biol Chem; 2024 Apr; 300(4):107208. PubMed ID: 38521502 [TBL] [Abstract][Full Text] [Related]
14. A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23. Saito Y; Yin D; Kubota N; Wang X; Filliol A; Remotti H; Nair A; Fazlollahi L; Hoshida Y; Tabas I; Wangensteen KJ; Schwabe RF Gastroenterology; 2023 Jun; 164(7):1279-1292. PubMed ID: 36894036 [TBL] [Abstract][Full Text] [Related]
15. The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis. Zhou Y; Huang T; Cheng AS; Yu J; Kang W; To KF Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805820 [TBL] [Abstract][Full Text] [Related]
16. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer. Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949 [TBL] [Abstract][Full Text] [Related]
17. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509 [TBL] [Abstract][Full Text] [Related]
18. Identification of resistance mechanisms to small-molecule inhibition of TEAD-regulated transcription. Kulkarni A; Mohan V; Tang TT; Post L; Chan YC; Manning M; Thio N; Parker BL; Dawson MA; Rosenbluh J; Vissers JH; Harvey KF EMBO Rep; 2024 Sep; 25(9):3944-3969. PubMed ID: 39103676 [TBL] [Abstract][Full Text] [Related]
19. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma. Zhang J; Liu P; Tao J; Wang P; Zhang Y; Song X; Che L; Sumazin P; Ribback S; Kiss A; Schaff Z; Cigliano A; Dombrowski F; Cossu C; Pascale RM; Calvisi DF; Monga SP; Chen X Am J Pathol; 2019 May; 189(5):1077-1090. PubMed ID: 30794805 [TBL] [Abstract][Full Text] [Related]
20. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells. Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]